Seres Therapeutics Inc (MCRB)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | PS Planned sale |
See Remarks Officer |
3,338
-3.3%
0.81USD 2,704 |
3,338 -3.3% | 0.81 | USD 2,704 | |
| 2025-02-19 | 2025-02-18 | PS Planned sale |
See Remarks Officer |
3,953
-4.5%
0.81USD 3,204 |
3,953 -4.5% | 0.81 | USD 3,204 | |
| 2025-02-19 | 2025-02-18 | PS Planned sale |
See Remarks Officer |
4,416
-10.0%
0.81USD 3,579 |
4,416 -10.0% | 0.81 | USD 3,579 | |
| 2025-02-19 | 2025-02-18 | PS Planned sale |
CEO and President Executive Director |
12,726
-6.2%
0.81USD 10,314 |
12,726 -6.2% | 0.81 | USD 10,314 | |
| 2025-02-19 | 2025-02-18 | PS Planned sale |
Chief Legal Officer and EVP Officer |
4,300
-2.9%
0.81USD 3,485 |
4,300 -2.9% | 0.81 | USD 3,485 | |
| 2024-11-19 | 2024-11-18 | PS Planned sale |
Chief Legal Officer and EVP Officer |
878
-0.6%
0.54USD 475 |
878 -0.6% | 0.54 | USD 475 | |
| 2024-11-19 | 2024-11-18 | PS Planned sale |
See Remarks Officer |
977
-2.9%
0.54USD 528 |
977 -2.9% | 0.54 | USD 528 | |
| 2024-11-19 | 2024-11-18 | PS Planned sale |
See Remarks Officer |
927
-1.2%
0.54USD 501 |
927 -1.2% | 0.54 | USD 501 | |
| 2024-11-19 | 2024-11-18 | PS Planned sale |
See Remarks Officer |
735
-0.8%
0.54USD 398 |
735 -0.8% | 0.54 | USD 398 | |
| 2024-11-19 | 2024-11-18 | PS Planned sale |
CEO and President Executive Director |
2,505
-1.4%
0.54USD 1,355 |
2,505 -1.4% | 0.54 | USD 1,355 | |
| 2024-10-29 | 2024-10-28 | PS Planned sale |
See Remarks Officer |
4,334
-12.5%
0.69USD 2,991 |
4,334 -12.5% | 0.69 | USD 2,991 | |
| 2024-10-29 | 2024-10-28 | PS Planned sale |
See Remarks Officer |
2,983
-3.3%
0.69USD 2,059 |
2,983 -3.3% | 0.69 | USD 2,059 | |
| 2024-10-29 | 2024-10-28 | PS Planned sale |
Chief Legal Officer and EVP Officer |
4,259
-3.1%
0.69USD 2,939 |
4,259 -3.1% | 0.69 | USD 2,939 | |
| 2024-10-29 | 2024-10-28 | PS Planned sale |
See Remarks Officer |
3,984
-5.0%
0.69USD 2,749 |
3,984 -5.0% | 0.69 | USD 2,749 | |
| 2024-10-29 | 2024-10-28 | PS Planned sale |
CEO and President Executive Director |
8,748
-5.0%
0.69USD 6,037 |
8,748 -5.0% | 0.69 | USD 6,037 | |
| 2024-08-19 | 2024-08-16 | PS Planned sale |
Chief Legal Officer and EVP Officer |
873
-0.7%
0.84USD 733 |
873 -0.7% | 0.84 | USD 733 | |
| 2024-08-19 | 2024-08-16 | PS Planned sale |
See Remarks Officer |
973
-4.4%
0.84USD 817 |
973 -4.4% | 0.84 | USD 817 | |
| 2024-08-19 | 2024-08-16 | PS Planned sale |
See Remarks Officer |
1,128
-1.4%
0.84USD 948 |
1,128 -1.4% | 0.84 | USD 948 | |
| 2024-08-19 | 2024-08-16 | PS Planned sale |
CEO and President Executive Director |
2,518
-1.7%
0.84USD 2,115 |
2,518 -1.7% | 0.84 | USD 2,115 | |
| 2024-08-19 | 2024-08-16 | PS Planned sale |
See Remarks Officer |
923
-1.4%
0.84USD 775 |
923 -1.4% | 0.84 | USD 775 | |
| 2024-08-19 | 2024-08-16 | PS Planned sale |
See Remarks Officer |
728
-0.9%
0.84USD 612 |
728 -0.9% | 0.84 | USD 612 | |
| 2024-08-06 | 2024-08-05 | PS Planned sale |
See Remarks Officer |
24,480
-23.8%
1.08USD 26,534 |
24,480 -23.8% | 1.08 | USD 26,534 | |
| 2024-05-17 | 2024-05-15 | PS Planned sale |
CEO and President Executive Director |
2,435
-1.7%
0.94USD 2,289 |
2,435 -1.7% | 0.94 | USD 2,289 | |
| 2024-05-17 | 2024-05-15 | PS Planned sale |
Chief Legal Officer and EVP Officer |
843
-0.7%
0.94USD 792 |
843 -0.7% | 0.94 | USD 792 | |
| 2024-05-17 | 2024-05-15 | PS Planned sale |
See Remarks Officer |
703
-3.8%
0.94USD 661 |
703 -3.8% | 0.94 | USD 661 | |
| 2024-05-17 | 2024-05-15 | PS Planned sale |
See Remarks Officer |
1,090
-1.4%
0.94USD 1,025 |
1,090 -1.4% | 0.94 | USD 1,025 | |
| 2024-05-17 | 2024-05-15 | PS Planned sale |
See Remarks Officer |
891
-1.3%
0.94USD 838 |
891 -1.3% | 0.94 | USD 838 | |
| 2024-05-17 | 2024-05-15 | PS Planned sale |
See Remarks Officer |
939
-4.7%
0.94USD 883 |
939 -4.7% | 0.94 | USD 883 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
See Remarks Officer |
4,170
-6.2%
1.08USD 4,504 |
4,170 -6.2% | 1.08 | USD 4,504 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
Chief Legal Officer and EVP Officer |
3,939
-3.2%
1.08USD 4,254 |
3,939 -3.2% | 1.08 | USD 4,254 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
See Remarks Officer |
5,010
-6.4%
1.08USD 5,411 |
5,010 -6.4% | 1.08 | USD 5,411 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
CEO and President Executive Director |
11,549
-7.9%
1.08USD 12,473 |
11,549 -7.9% | 1.08 | USD 12,473 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
Chief Financial Officer Officer |
3,939
-2.1%
1.08USD 4,254 |
3,939 -2.1% | 1.08 | USD 4,254 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
See Remarks Officer |
3,374
-17.7%
1.08USD 3,644 |
3,374 -17.7% | 1.08 | USD 3,644 | |
| 2024-02-16 | 2024-02-16 | PS Planned sale |
See Remarks Officer |
4,400
-20.6%
1.08USD 4,752 |
4,400 -20.6% | 1.08 | USD 4,752 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
Chief Financial Officer Officer |
4,066
-2.3%
1.35USD 5,489 |
4,066 -2.3% | 1.35 | USD 5,489 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
See Remarks Officer |
3,886
-6.5%
1.35USD 5,246 |
3,886 -6.5% | 1.35 | USD 5,246 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
See Remarks Officer |
2,904
-6.0%
1.35USD 3,920 |
2,904 -6.0% | 1.35 | USD 3,920 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
See Remarks Officer |
4,232
-30.8%
1.35USD 5,713 |
4,232 -30.8% | 1.35 | USD 5,713 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
CEO and President Executive Director |
8,552
-6.9%
1.35USD 11,545 |
8,552 -6.9% | 1.35 | USD 11,545 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
See Remarks Officer |
4,066
-5.7%
1.35USD 5,489 |
4,066 -5.7% | 1.35 | USD 5,489 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
See Remarks Officer |
2,907
-25.6%
1.35USD 3,924 |
2,907 -25.6% | 1.35 | USD 3,924 | |
| 2023-10-31 | 2023-10-30 | PS Planned sale |
Chief Legal Officer and EVP Officer |
4,156
-3.5%
1.35USD 5,611 |
4,156 -3.5% | 1.35 | USD 5,611 | |
| 2023-05-01 | 2023-04-28 | PS Planned sale |
See Remarks Officer |
7,038
-10.5%
5.19USD 36,527 |
7,038 -10.5% | 5.19 | USD 36,527 | |
| 2022-10-31 | 2022-10-31 | PS Planned sale |
See Remarks Officer |
5,012
-9.7%
7.93USD 39,745 |
5,012 -9.7% | 7.93 | USD 39,745 | |
| 2022-07-07 | 2022-07-05 | B Purchase |
Nutritional Health LTP Fund General Partner LLC Large shareholder |
5,825,495
+inf%
3.15USD 18,350,309 |
5,825,495 +inf% | 3.15 | USD 18,350,309 | |
| 2022-07-07 | 2022-07-05 | B Purchase |
Nutritional Health LTP Fund General Partner LLC Large shareholder |
2,912,748
+98.3%
3.15USD 9,175,156 |
2,912,748 +98.3% | 3.15 | USD 9,175,156 | |
| 2020-12-03 | 2020-12-01 | PS Planned sale |
See Remarks Officer |
9,841
-100.0%
28.34USD 278,894 |
9,841 -100.0% | 28.34 | USD 278,894 | |
| 2020-12-03 | 2020-12-01 | PS Planned sale |
See Remarks Officer |
26,265
-72.7%
27.56USD 723,863 |
26,265 -72.7% | 27.56 | USD 723,863 | |
| 2020-12-03 | 2020-12-01 | PS Planned sale |
See Remarks Officer |
55,706
-60.7%
26.56USD 1,479,551 |
55,706 -60.7% | 26.56 | USD 1,479,551 | |
| 2019-11-25 | 2019-11-22 | PS Planned sale |
Chapman Marcus See Remarks Officer |
3,400
-28.3%
3.91USD 13,297 |
3,400 -28.3% | 3.91 | USD 13,297 | |
| 2019-06-20 | 2019-06-18 | B Purchase | Large shareholder |
4,444,444
+inf%
2.25USD 9,999,999 |
4,444,444 +inf% | 2.25 | USD 9,999,999 | |
| 2019-06-20 | 2019-06-18 | B Purchase | Large shareholder |
4,444,444
+inf%
2.25USD 9,999,999 |
4,444,444 +inf% | 2.25 | USD 9,999,999 | |
| 2019-01-29 | 2019-01-28 | S Sale |
Chief Legal Officer and EVP Officer |
5,471
-25.4%
5.75USD 31,478 |
5,471 -25.4% | 5.75 | USD 31,478 | |
| 2019-01-29 | 2019-01-28 | S Sale |
See Remarks Officer |
4,378
-25.4%
5.75USD 25,188 |
4,378 -25.4% | 5.75 | USD 25,188 | |
| 2018-12-19 | 2018-12-17 | PS Planned sale |
Aunins John G. Chief Technology Officer & EVP Officer |
14,282
-16.0%
6.39USD 91,313 |
14,282 -16.0% | 6.39 | USD 91,313 | |
| 2018-11-19 | 2018-11-15 | PS Planned sale |
Aunins John G. See Remarks Officer |
14,279
-13.8%
8.26USD 117,912 |
14,279 -13.8% | 8.26 | USD 117,912 | |
| 2018-10-16 | 2018-10-15 | PS Planned sale |
Aunins John G. See Remarks Officer |
14,279
-12.1%
5.94USD 84,800 |
14,279 -12.1% | 5.94 | USD 84,800 | |
| 2018-09-19 | 2018-09-17 | PS Planned sale |
Aunins John G. See Remarks Officer |
14,279
-10.8%
7.27USD 103,875 |
14,279 -10.8% | 7.27 | USD 103,875 | |
| 2018-09-11 | 2018-09-07 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
1,810
-0.8%
9.00USD 16,291 |
1,810 -0.8% | 9.00 | USD 16,291 | |
| 2018-09-06 | 2018-09-06 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
3,013
-1.4%
9.04USD 27,235 |
3,013 -1.4% | 9.04 | USD 27,235 | |
| 2018-09-06 | 2018-09-05 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
9,505
-4.2%
9.12USD 86,714 |
9,505 -4.2% | 9.12 | USD 86,714 | |
| 2018-09-19 | 2018-08-15 | PS Planned sale |
Aunins John G. See Remarks Officer |
14,279
-9.7%
7.57USD 108,069 |
14,279 -9.7% | 7.57 | USD 108,069 | |
| 2018-07-18 | 2018-07-15 | PS Planned sale |
Aunins John G. Chief Technology Officer & EVP Officer |
14,279
-8.1%
8.10USD 115,726 |
14,279 -8.1% | 8.10 | USD 115,726 | |
| 2018-07-12 | 2018-07-11 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
1,010
-0.4%
9.01USD 9,099 |
1,010 -0.4% | 9.01 | USD 9,099 | |
| 2018-07-10 | 2018-07-10 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
5,989
-2.6%
9.05USD 54,208 |
5,989 -2.6% | 9.05 | USD 54,208 | |
| 2018-07-10 | 2018-07-09 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
10,981
-4.6%
9.14USD 100,351 |
10,981 -4.6% | 9.14 | USD 100,351 | |
| 2018-07-10 | 2018-07-06 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
15,366
-6.3%
9.14USD 140,507 |
15,366 -6.3% | 9.14 | USD 140,507 | |
| 2018-06-29 | 2018-06-29 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
4,496
-1.9%
9.10USD 40,915 |
4,496 -1.9% | 9.10 | USD 40,915 | |
| 2018-06-29 | 2018-06-28 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
21,560
-8.6%
9.15USD 197,375 |
21,560 -8.6% | 9.15 | USD 197,375 | |
| 2018-06-27 | 2018-06-27 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
16,991
-6.9%
9.03USD 153,408 |
16,991 -6.9% | 9.03 | USD 153,408 | |
| 2018-06-27 | 2018-06-26 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
21,224
-8.5%
9.19USD 195,133 |
21,224 -8.5% | 9.19 | USD 195,133 | |
| 2018-06-27 | 2018-06-25 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
26,752
-10.5%
9.21USD 246,504 |
26,752 -10.5% | 9.21 | USD 246,504 | |
| 2018-06-22 | 2018-06-22 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
40,057
-14.4%
9.36USD 374,761 |
40,057 -14.4% | 9.36 | USD 374,761 | |
| 2018-06-22 | 2018-06-21 | PS Planned sale |
Pomerantz Roger President and CEO Executive Director |
18,987
-6.4%
9.06USD 172,094 |
18,987 -6.4% | 9.06 | USD 172,094 |